The drug discovery technology provider has now raised about $16m, with pharmaceutical company Eli Lilly co-leading the firm's series C round.

The Amgen and Celgene-backed biotechnology company, which has raised $72m across two venture rounds, will use the proceeds to advance two product candidates.

The Indian healthcare company is planning take on external investors for a new fund that would continue its corporate venture capital investments.

Imperial and University College London's TTOs team with TSB centre to create a joint venture to tackle acute myeloid leukaemia.

Technology manufacturing giant Foxconn invests in the Stanford spin-out.

Oxford Capital reinvests in its portfolio company which aims to control insects.

The online healthcare appointment service is set to raise a $152m series D round that would include existing investor DST Global.

The Medtronic-backed medical device developer has filed for an $80m IPO, after raising almost $90m in earlier funding.

The Ascension Health-backed ophthalmic treatment developer will use the proceeds to advance its lead product through Phase 2 and 3 clinical trials.

Johnson & Johnson and GlaxoSmithKline both invested in the round, which will be used to speed up development of Navitor's drug pipeline.